|
In the beginning of this year, we’ve been busy with the selection of studies from our 2021 national call and from our BeNeFIT-2 call in collaboration with ZonMw. We’ve also signed several contracts from studies selected in previous calls, and we hope those studies will start to recruit soon. We’re also happy to announce the opening of our annual investigator-led call later this year. Lastly but definitely not least, we are proud to share that our programme has recently reached the milestone of more than 20,000 participants included in KCE Trials funded studies. We appreciate the hard work that this represents and want to congratulate all investigators and recruiting staff and say a big ‘Thank You’ to all of the participants and their families. KCE Trials team |
Funding Opportunities
|
CALL OPENING SOON Our 7th national investigator-led call for proposals will open in May 2022 and will have the same scope and eligibility criteria as the 2021 call. A strengthening workshop will be organised online in June. More information will be provided on our website soon. A specific announcement will also be sent. |
Progress in funded studies
We are happy to announce the following important milestones have been reached in the trials below:
| SURLYM FPI |
|
The SurLym study has recruited its first patient. This study includes patients with arm or leg lymphoedema and compares lymphatic reconstructive surgery versus no surgery, in addition to decongestive lymphatic therapy (usual care). The study will recruit 180 participants across three sites. The chief investigator is Pr Nele Devoogdt from UZ Leuven. |
| SOPRANO Contract Signed |
The SOPRANO trial compares two strategies to administer biological treatments to prevent postoperative endoscopic disease recurrence in Crohn's disease. The chief investigator is Prof. Dr. Ferrante from UZ Leuven. 352 participants will be included in this study across 24 sites. This study is also one of the first Belgian studies submitted through the CTIS, the new European platform for approval of clinical trials on drugs. Read more>> |
|
| 3 Long-COVID studies Contracts Signed |
Contracts for the three studies assessing treatments for long-COVID have been signed:
These proof-of-concept studies will assess different types of treatments (combined nutritional and physiotherapy, pulmonary rehabilitation and psycho-educational cognitive programme) for patients with long-COVID and hope to have initial results next year. |
|
| TreatPaCS Contract Signed |
Treatment for preschool age children who stutter: A randomised, multicentre, non-inferiority parallel group pragmatic trial with Mini-KIDS, social cognitive behaviour treatment and the Lidcombe Program. The chief investigator is Sabine Van Eerdenbrugh from the Thomas More Mechelen-Antwerpen vzw. 249 children will be recruited in 30 practices of speech therapists. Read More>> |
The KCE Trials complete portfolio comprises 40 studies. more info>>
Impact
The latest 5 scientific publications are presented below, and all can be found on the last tab of our dynamic dashboards.
More than 20 000 patients have been recruited so far in KCE funded trials !
Check our dynamic dashboard for real-time recruitment data for all KCE Trials funded studies
More info
